Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 145Carcinoma, Intraductal, Noninfiltrating 12Breast Carcinoma In Situ 10Neoplasm Metastasis 9Breast Neoplasms, Male 9Neoplasms 5Ovarian Neoplasms 4Prostatic Neoplasms 3Inflammatory Breast Neoplasms 3Gliosarcoma 3Glioma 3Glioblastoma 3Fallopian Tube Neoplasms 3Endometrial Neoplasms 3Central Nervous System Neoplasms 3Carcinoma, Ductal, Breast 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Sarcoma 2Oligodendroglioma 2Multiple Endocrine Neoplasia Type 1 2Liver Neoplasms 2Hot Flashes 2Glioma, Subependymal 2Fibroadenoma 2Ependymoma 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Astrocytoma 2Thyroid Neoplasms 1

Interventions

ziprasidone 1Tamoxifen 1Olanzapine 1Lysine Acetyltransferase 5 1Goserelin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hyperlipidemias × Tamoxifen × Clear all
NCT00827307 2011-08-08

Zoladex Plus Tamoxifen in Breast Cancer

Zhejiang Cancer Hospital

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms, Hyperlipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡